Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1278-1284

  Mukhopadhyay, Debabrata ^a,b   Nagy, Janice A ^b   Manseau, Eleanor J ^b   Dvorak, Harold F ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CYTOKINE PRODUCTION; IMMUNOREGULATION; MALE; MESENTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0032521212     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., and Giovinco, P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J. Immunol., 122: 166-174, 1979.
2. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
3. Dvorak, H. F. Tumors. Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315: 1650-1659, 1986.
4. Berse, B., Brown, L. F., Van De Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 3: 211-220, 1992.
5. Ferrara, N., Houck, K., Jakeman, L., Winer, J., and Leung, D. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
6. Senger, D., Van deWater, L., Brown, L. F., Nagy, J., Yeo, K-T., Yeo, T-K., Berse, B., Jackman, R., Dvorak, A., and Dvorak, H. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
7. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
8. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: I. D. Goldberg and E. M. Rosen (eds.), Regulation of Angiogenesis, pp. 233-269. Basel: Birkhäuse Verlag, 1997.
9. Dvorak, H. F., Dvorak, A. M., Manseau, E. J., Wiberg, L., and Churchill, W. H. Fibrin-gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J. Natl. Cancer Inst., 62: 1459-1472, 1979.
10. Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J., and Dvorak, A. M. Fibrin-containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest., 57: 673-686, 1987.
11. Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van de Water, L., Dvorak, A. M., and Dvorak, H. F. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta, 948: 305-326, 1989.
12. Nagy, J. A., Meyers, M. S., Masse, E. M., Herzberg, K. T., and Dvorak, H. F. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res., 55: 369-375, 1995.
13. Nagy, J. A., Masse, E. M., Herzberg, K. T., Meyers, M. S., Yeo, K. T., Yeo, T. K., Sioussat, T. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
14. Nagy, J., Morgan, E., Herzberg, K., Manseau, E., Dvorak, A., and Dvorak, H. Pathogenesis of ascites tumor growth. Angiogenesis, vascular remodeling and stroma formation in the peritoneal lining. Cancer Res., 55: 376-385, 1995.
15. Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., and van de Water, L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med., 176: 1375-1379, 1992.
16. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., and Dvorak, H. F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med., 180: 1141-1146, 1994.
17. Fava, R. A., Olsen, N. J., Spencer, G. G., Yeo. K. T., Yeo, T. K., Berse, B., Jackman, R. W., Senger, D. R., Dvorak, H. F., and Brown, L. F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346, 1994.
18. Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., and Berse, B. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol., 145: 574-584, 1994.
19. Brown, L. F., Olbricht, S. M., Berse, B., Jackman, R. W., Matsueda, G., Tognazzi, K. A., Manseau, E. J., Dvorak, H. F., and Van de Water, L. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J. Immunol., 154: 2801-2807, 1995.
20. Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84: 1470-1478, 1989.
21. Conn, G., Soderman, D. D., Schaeffer, M-T., Wile, M., Hatcher, V. B., and Thomas, K. A. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc. Natl. Acad Sci. USA, 87: 1323-1327, 1990.
22. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Meller, N. P. H., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest FIk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
23. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
24. Watanabe, Y., Lee, S. W., Detmar, M., Ajioka, I., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene, 14: 2025-2032, 1997.
25. Brown, L. F., Detmar, M., Tognazzi, K., Abu-Jawdeh, G., and Iruela-Arispe, M. L. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab. Invest., 76: 245-255, 1997.
26. Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N., and Williams, L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA, 90: 7533-7537, 1993.
27. Terman, B., Dougher-Vermazen, M., Carrion, M., Dimitrov, D., Armellino, D., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
28. Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., and King, G. L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest., 98: 2018-2026, 1996.
29. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10: 135-147, 1995.
30. Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem., 270: 6729-6733, 1995.
31. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol., 138: 213-221, 1991.
32. 2+-induced regulation of ion channel and MAP kinase functions. Nature (Lond.), 376: 737-745, 1995.
33. Avraham, S., London, R., Fu, Y., Ota, S., Hiregowdara, D., Li, J., Jiang, S., Pasztor, L. M., White, R. A., Groopman, J. E. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J. Biol. Chem., 270: 27742-27751, 1995.
34. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., and Parsons, J. T. pp125FAK: a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA, 89: 5192-5196, 1992.
35. Majno, G., Shea, S. M., and Leventhal, M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J. Cell. Biol., 42: 647-672, 1969.
36. Sano, M., Kohno, M., and Iwanaga, M. The activation and nuclear translocation of extracellular signal-regulated kinases (ERK-1 and -2) appear not to be required for elongation of neuntes in PC12D cells. Brain Res., 688: 213-218, 1995.
37. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76: 1025-1037, 1994.
38. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Ruble, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
39. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R., and Karin, M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol., 14: 6683-6688, 1994.
40. Westwick, J. K., Weitzel, C., Minden, A., Karin, M., and Brenner, D. A. Tumor necrosis factor a stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem., 269: 26396-26401, 1994.
41. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R. J., Johnson, G. L., and Karin, M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Washington DC). 266: 1719-1723, 1994.
42. Tokiwa, G., Dikic, L. Lev, S., and Schlessinger, J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science (Washington DC), 273: 792-794, 1996.